Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Enhanced Photoenergy Harvesting and Extreme Thomson Effect in Hydrodynamic Electronic Systems.

Andersen TI, Smith TB, Principi A.

Phys Rev Lett. 2019 Apr 26;122(16):166802. doi: 10.1103/PhysRevLett.122.166802.

PMID:
31075009
2.

Electron-phonon instability in graphene revealed by global and local noise probes.

Andersen TI, Dwyer BL, Sanchez-Yamagishi JD, Rodriguez-Nieva JF, Agarwal K, Watanabe K, Taniguchi T, Demler EA, Kim P, Park H, Lukin MD.

Science. 2019 Apr 12;364(6436):154-157. doi: 10.1126/science.aaw2104.

PMID:
30975884
3.

Efficiency of Launching Highly Confined Polaritons by Infrared Light Incident on a Hyperbolic Material.

Dai S, Ma Q, Yang Y, Rosenfeld J, Goldflam MD, McLeod A, Sun Z, Andersen TI, Fei Z, Liu M, Shao Y, Watanabe K, Taniguchi T, Thiemens M, Keilmann F, Jarillo-Herrero P, Fogler MM, Basov DN.

Nano Lett. 2017 Sep 13;17(9):5285-5290. doi: 10.1021/acs.nanolett.7b01587. Epub 2017 Aug 17.

4.

Magnetic resonance spectroscopy of an atomically thin material using a single-spin qubit.

Lovchinsky I, Sanchez-Yamagishi JD, Urbach EK, Choi S, Fang S, Andersen TI, Watanabe K, Taniguchi T, Bylinskii A, Kaxiras E, Kim P, Park H, Lukin MD.

Science. 2017 Feb 3;355(6324):503-507. doi: 10.1126/science.aal2538. Epub 2017 Jan 19.

PMID:
28104795
5.

Competing channels for hot-electron cooling in graphene.

Ma Q, Gabor NM, Andersen TI, Nair NL, Watanabe K, Taniguchi T, Jarillo-Herrero P.

Phys Rev Lett. 2014 Jun 20;112(24):247401. Epub 2014 Jun 19.

PMID:
24996107
6.

[Neck pain with and without affection of nerve roots].

Nygaard ØP, Rø M, Andersen TI, Zwart JA.

Tidsskr Nor Laegeforen. 2010 Nov 18;130(22):2252-5. doi: 10.4045/tidsskr.09.1285. Review. Norwegian.

7.

siRNA: a potential tool for future breast cancer therapy?

Størvold GL, Andersen TI, Perou CM, Frengen E.

Crit Rev Oncog. 2006 Jul;12(1-2):127-50. Review.

PMID:
17078209
8.

The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1684-8.

9.

BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.

Kringen P, Egedal S, Pedersen JC, Harbitz TB, Tveit KM, Berg K, Børresen-Dale AL, Andersen TI.

Electrophoresis. 2002 Dec;23(24):4085-91.

PMID:
12481264
10.

Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism.

Jugessur A, Frost P, Andersen TI, Steine S, Lindblom A, Børresen-Dale AL, Eiken HG.

J Mol Med (Berl). 2000;78(10):580-7.

PMID:
11199332
11.

Screening breast cancer patients for Norwegian ATM mutations.

Laake K, Vu P, Andersen TI, Erikstein B, Kåresen R, Lonning PE, Skovlund E, Børresen-Dale AL.

Br J Cancer. 2000 Dec;83(12):1650-3.

12.

Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients.

Nedelcheva Kristensen V, Andersen TI, Erikstein B, Geitvik G, Skovlund E, Nesland JM, Børresen-Dale AL.

Pharmacogenetics. 1998 Oct;8(5):441-7. Erratum in: Pharmacogenetics 1999 Feb;9(1):following 127.

PMID:
9825836
13.

[Diagnostic molecular biology in breast cancer].

Andersen TI, Børresen-Dale AL.

Tidsskr Nor Laegeforen. 1998 Jun 10;118(15):2366-9. Review. Norwegian.

PMID:
9691806
14.

The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer.

Lothe RA, Hektoen M, Johnsen H, Meling GI, Andersen TI, Rognum TO, Lindblom A, Børresen-Dale AL.

Cancer Res. 1998 Jul 15;58(14):2923-4.

15.

[Diagnostic molecular biology in prostatic cancer].

Andersen TI.

Tidsskr Nor Laegeforen. 1998 May 30;118(14):2196-8. Review. Norwegian.

PMID:
9656817
16.

[Telomeres, telomerase and development of cancer].

Andersen TI.

Tidsskr Nor Laegeforen. 1998 May 20;118(13):2043-6. Review. Norwegian.

PMID:
9656791
17.

Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases.

Sørlie T, Andersen TI, Bukholm I, Børresen-Dale AL.

Breast Cancer Res Treat. 1998 Apr;48(3):259-64.

PMID:
9598872
18.

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.

Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL.

Pharmacogenetics. 1998 Feb;8(1):43-8.

PMID:
9511180
19.

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C, et al.

Cancer Res. 1998 Mar 1;58(5):1004-12.

20.

Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.

Andersen TI, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjaerg L, Dørum A, Møller P, Weber BL, Børresen-Dale AL.

Hum Mutat. 1998;11(2):166-74.

PMID:
9482581
21.

A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region.

Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Håkansson S, Andersen TI, Borg A, Børresen Dale AL, Lindblom A.

Cancer Res. 1997 Jun 15;57(12):2474-7.

22.

Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.

Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL.

Genes Chromosomes Cancer. 1997 Mar;18(3):175-80.

PMID:
9071570
23.

A common BRCA1 mutation in Norwegian breast and ovarian cancer families?

Andersen TI, Børresen AL, Møller P.

Am J Hum Genet. 1996 Aug;59(2):486-7. No abstract available.

24.

TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.

Chitemerere M, Andersen TI, Holm R, Karlsen F, Børresen AL, Nesland JM.

Breast Cancer Res Treat. 1996;41(2):103-9.

PMID:
8944328
25.

Genetic heterogeneity in breast cancer susceptibility.

Andersen TI.

Acta Oncol. 1996;35(4):407-10.

PMID:
8695152
26.

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

Børresen AL, Andersen TI, Eyfjörd JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S, et al.

Genes Chromosomes Cancer. 1995 Sep;14(1):71-5.

PMID:
8527388
28.

Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population.

Heimdal K, Andersen TI, Skrede M, Fosså SD, Berg K, Børresen AL.

Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):123-6.

29.
30.

Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.

Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Børresen AL.

Hum Genet. 1994 Dec;94(6):665-70.

PMID:
7989041
31.

Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques.

Rosenberg C, Andersen TI, Nesland JM, Lier ME, Brøgger A, Børresen AL.

Cancer Genet Cytogenet. 1994 Jul 1;75(1):1-5.

PMID:
8039157
32.

Genome scanning of breast cancers by two-dimensional DNA typing.

Verwest AM, de Leeuw WJ, Molijn AC, Andersen TI, Börresen AL, Mullaart E, Uitterlinden AG, Vijg J.

Br J Cancer. 1994 Jan;69(1):84-92.

33.

Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

Lothe RA, Peltomäki P, Meling GI, Aaltonen LA, Nyström-Lahti M, Pylkkänen L, Heimdal K, Andersen TI, Møller P, Rognum TO, et al.

Cancer Res. 1993 Dec 15;53(24):5849-52.

PMID:
8261392
34.

Prognostic significance of TP53 alterations in breast carcinoma.

Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL.

Br J Cancer. 1993 Sep;68(3):540-8.

35.

Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.

Lindblom A, Skoog L, Andersen TI, Rotstein S, Nordenskjöld M, Larsson C.

Hum Genet. 1993 Mar;91(1):6-12.

PMID:
8454289
36.

Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.

Ottestad L, Andersen TI, Nesland JM, Skrede M, Tveit KM, Nustad K, Børresen AL.

Acta Oncol. 1993;32(3):289-94.

PMID:
8100712
37.

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.

Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH.

Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7.

38.

Screening for germ line TP53 mutations in breast cancer patients.

Børresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen B, Hovig E, Malkin D, et al.

Cancer Res. 1992 Jun 1;52(11):3234-6.

39.

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.

Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al.

N Engl J Med. 1992 May 14;326(20):1309-15. Erratum in: N Engl J Med. 1997 Mar 6;336(10):734.

40.

Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.

Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, Børresen AL.

Genes Chromosomes Cancer. 1992 Mar;4(2):113-21.

PMID:
1373310
41.

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

Børresen AL, Hovig E, Smith-Sørensen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ, Friend SH.

Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8405-9.

42.

Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.

Børresen AL, Andersen TI, Tretli S, Heiberg A, Møller P.

Genes Chromosomes Cancer. 1990 Nov;2(4):339-40.

PMID:
2268581
43.
44.

Early Alaska mental health.

Andersen TI.

Alaska Med. 1988 May-Jun;30(3):91-4. No abstract available.

PMID:
3041872

Supplemental Content

Loading ...
Support Center